The TME of LM has a highly immunosuppressive phenotype, which is indicated by the loss of antigen-specific CD8+ T cells; thus, this TME promotes the invasive and metastatic capabilities of primary cancer cells [24, 25]. The gene discussed is CD8A; the disease is cancer.